M&AHealthcareSIGNED
Intersurgical / Teleflex merger inquiry launched by UK regulator
Acquirer
Intersurgical AG
Target
Teleflex Incorporated's acute care and interventional urology businesses
The UK's Competition and Markets Authority (CMA) has initiated a merger inquiry into the anticipated acquisition by Intersurgical AG of Teleflex Incorporated's acute care and interventional urology businesses. The CMA is seeking public views on the transaction.
✦ Meridian Analysis
Intersurgical AG has signed an agreement to acquire Teleflex Incorporated’s acute‑care and interventional urology businesses, and the deal is now subject to a merger inquiry by the UK Competition and Markets Authority (CMA). The CMA’s invitation to comment, issued on 20 October 2026, marks the first stage of its information‑gathering process and precedes a formal phase‑1 investigation. Concurrently, control of Intersurgical itself will pass to private‑equity investors Armira Beteiligungen GmbH & Co. KG and TA Associates Management, L.P.
Deal professionals will be watching for the undisclosed purchase price and any earn‑out or contingent consideration tied to post‑closing performance. The composition of the financing package, including the proportion of senior versus mezzanine debt, remains unknown, as do the advisers representing each side. A timetable for the CMA’s phase‑1 decision and any subsequent remedies will be critical for assessing the transaction’s closing risk.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.